Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185510
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2005-09-15
Brief Title:
Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
Double-Blind Placebo Controlled Randomized Multicenter Parallel-Group Study to Compare the Efficacy and Safety of Advantan Cream Twice Weekly With Advabase Cream During a Maintenance Phase of 16 Weeks After Successful Treatment of Atopic Dermatitis With Advantan Cream
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose of the study
One bothering feature of atopic dermatitis is its relapsing nature Hence it is worthwhile to test modes how to efficiently prevent relapses or at least increase the time until the disease recurs In order to give recommendations to other patients this study is to scientifically describe efficacy and safety of a given regimen namely a maintenance therapy with two days a week Advantan
One bothering feature of atopic dermatitis is its relapsing nature Hence it is worthwhile to test modes how to efficiently prevent relapses or at least increase the time until the disease recurs In order to give recommendations to other patients this study is to scientifically describe efficacy and safety of a given regimen namely a maintenance therapy with two days a week Advantan
Detailed Description:
The study has initially been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG Germany
Intendis GmbH a Bayer HealthCare company is the sponsor of the trial
Intendis GmbH a Bayer HealthCare company is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-002673-22 | EUDRACT_NUMBER | None | None |
| 309189 | OTHER | Company internal | None |